Medicare Enrolled
Dr. Lianne Cavell, MD
Gastroenterology · Delray Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cavell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cavell?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cavell
Dr. Lianne Cavell is a gastroenterology specialist in Delray Beach, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Cavell performed 22,328 Medicare services across 1,192 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cavell received a total of $7,550 from 49 pharmaceutical and/or device companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cavell is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 1% volume in FL
$7,550 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 115795 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗22,328
Medicare services
Top 1% in FL for gastroenterology
1,192
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,313 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
21,000 | $17 | $52 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
329 | $101 | $348 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
190 | $69 | $237 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
125 | $70 | $1,168 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
114 | $223 | $1,426 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
97 | $94 | $1,497 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $131 | $542 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
79 | $53 | $223 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
61 | $87 | $358 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
48 | $190 | $1,109 |
| Endoscopic ultrasound of esophagus, stomach, or upper small bowel An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope. |
46 | $187 | $958 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
32 | $196 | $1,081 |
| Endoscopic ultrasound-guided needle biopsy A procedure using an ultrasound-equipped endoscope to guide a needle for tissue sampling of the esophagus, stomach, or upper small bowel. |
26 | $222 | $938 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
25 | $107 | $1,000 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $145 | $670 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
15 | $93 | $861 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
14 | $60 | $245 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
12 | $109 | $3,249 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
12 | $98 | $344 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
94.5% high complexity
1.7% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,550
Total received (2018-2024)
Avg $1,079/year across 7 years
Top 24% in FL for gastroenterology
49
Companies
387
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,388 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$162 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,564
2023
$1,350
2022
$968
2021
$766
2020
$447
2019
$934
2018
$1,521
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$791
AbbVie Inc.
$650
ABBVIE INC.
$540
Ferring Pharmaceuticals Inc.
$505
AbbVie, Inc.
$455
Janssen Biotech, Inc.
$364
E.R. Squibb & Sons, L.L.C.
$352
Gilead Sciences, Inc.
$334
Celgene Corporation
$329
Takeda Pharmaceuticals U.S.A., Inc.
$275
Synergy Pharmaceuticals Inc
$231
Lilly USA, LLC
$226
Boston Scientific Corporation
$174
Merck Sharp & Dohme Corporation
$174
Allergan Inc.
$170
Celltrion USA Inc.
$147
GENZYME CORPORATION
$145
Intercept Pharmaceuticals, Inc.
$141
Merck Sharp & Dohme LLC
$136
NESTLE HEALTHCARE NUTRITION INC.
$116
Daiichi Sankyo Inc.
$105
Ardelyx, Inc.
$104
Phathom Pharmaceuticals, Inc.
$92
PFIZER INC.
$90
RedHill Biopharma Inc.
$88
Ironwood Pharmaceuticals, Inc
$80
QOL Medical, LLC
$73
Braintree Laboratories, Inc.
$72
INTERCEPT PHARMACEUTICALS, INC.
$64
Nestle HealthCare Nutrition Inc.
$60
IRONWOOD PHARMACEUTICALS, INC
$50
Organon LLC
$39
Romark Laboratories, LC
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
UCB, Inc.
$33
VIVUS LLC
$29
Ipsen Biopharmaceuticals, Inc
$28
Evoke Pharma, Inc.
$22
Echosens North America, Inc.
$22
Amgen Inc.
$21
AIMMUNE THERAPEUTICS, INC.
$21
Novo Nordisk Inc
$20
Lucid Diagnostics Inc.
$18
Prometheus Laboratories Inc.
$18
Medtronic USA, Inc.
$16
Allergan, Inc.
$15
Shire North American Group Inc
$15
Alexion Pharmaceuticals, Inc.
$14
FUJIFILM Healthcare Americas Corporation
$14
Top 3 companies account for 26.2% of total payments
Associated products mentioned in payments ›
AMJEVITA · APRISO · AXIOS · Aemcolo · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · Bylvay · CERVIDIL · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · Entyvio · FUJIFILM · Fibroscan · GATTEX · GIMOTI · HUMIRA · Humira · IBSRELA · INJECTAFER · INTERSTIM ICON · Kanuma · LINZESS · Linzess · MAVYRET · Mavyret · Morphabond ER · Motegrity · Movantik · OCALIVA · OMVOH · PLENVU · QSYMIA · Qsymia · REBYOTA · RENFLEXIS · RINVOQ · Resolution 360 Clip · SKYRIZI · STELARA · SUFLAVE · SUPREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS TABLETS · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · Wegovy · XELJANZ · XIFAXAN · XIFAXANIBSD · YUFLYMA · ZENPEP · ZEPATIER · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $34 per 100 Medicare services performed
Geographic Context
Gastroenterologists within 10 mi
130
Per 100K population
8.6
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cavell is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cavell experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Cavell performed 21,000 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cavell receive payments from pharmaceutical companies?
Yes. Dr. Cavell received a total of $7,550 from 49 companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cavell's costs compare to other gastroenterologists in Delray Beach?
Dr. Cavell's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cavell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Delray Beach
Browse gastroenterologists in Delray Beach ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in FL
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in FL
Which FL gastroenterologists receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology